To study the oral effect of jyotishmati vati in patient of aratavshaya

A RANDOMIZED OPEN LABELLED CONTROLLED CLINICAL TRIAL TO ASSESS AN EFFECT OF DURVA SWARASA BHAVIT JYOTISHMATI VATI IN ARTAVKSHAYA WITH SPECIAL REFERENCE TO OLIGOMENORRHEA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082543

Enrollment

Registered

2025-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age 15 to 35 yrs. Selection irrespective of marital status, parity, socio-economic status. Patients having signs & symptoms of Artavkshaya. Those having scanty menstrual bleeding. Those females having quantity of bleeding less than 80 ml . Hb less than 8gm

Exclusion criteria

Exclusion criteria: Known patients of blood dyscrasias. Known patients of major systemic diseases that are likely to influence menstrual rhythm. For e.g.; HTN, DM, TB, HIV, Thyroid, Nephrotic disorders. Known patients of malignancy, cervical erosion, polyp, endometriosis, tubo-ovarian mass. Known case of structural anomalies of genital organs. Patients using IUCD’s. Patients undergoing treatment for any other serious illness.

Design outcomes

Primary

Measure	Time frame
To study the efficacy of durva swaras bhavit jyotishmati vati in artavkshaya with special reference to oligomenorrheaTimepoint: 3 months	—

Secondary

Measure	Time frame
To study detail about artavkshaya To study properties of durva swaras bhavit jyotishmati vatiTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr. Manisha Rajkumar Vishwakarma

Siddhakala ayurved mahavidyalaya and research centre sangamner

vipulbhujbal1@gmail.com9960840214

Outcome results